Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving vision after brain injury

Official title: Visual Plasticity Following Brain Lesions

Run by Georgetown University · NCT07105358 · Data updated 2026-11-12

It tests whether gentle brain stimulation (transcranial random noise stimulation) plus visual training can help adults with homonymous hemianopia regain some of their lost visual field.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorGeorgetown University
Academic / other
Locations1 site (Washington D.C., District of Columbia)
StatusRecruiting
StartedJuly 17, 2025
Main results expectedJune 30, 2028
Study endsJune 30, 2028
Registry record updatedSeptember 14, 2026
Trial IDNCT07105358 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with unilateral or bilateral focal post-chiasmatic brain damage causing homonymous visual field loss who are at least three months post-stroke or TBI, or have a stable brain tumor within the past year.

Probably not a fit

People whose vision loss is caused primarily by eye (ocular) diseases, or who have severe unrelated CNS or unstable psychiatric conditions or recent substance abuse, are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial uses a double-blind, within-subject crossover design in adults with homonymous hemianopia from post-chiasmatic brain damage. Participants receive sessions of transcranial random noise stimulation (tRNS) paired with perceptual learning-based visual training and also receive sham stimulation in a separate period. Visual field measures and functional vision tasks are compared across the real and sham conditions to detect change. The design attempts to isolate the added effect of tRNS when combined with repeated training.

Why it matters

Potential benefit: If successful, the approach could restore portions of the visual field and improve everyday visual functioning for affected patients.

How similar studies have gone: Previous small trials combining noninvasive brain stimulation (including tRNS or tDCS) with perceptual training have shown modest and variable improvements, so the approach is promising but remains experimental.

Who can join: the full rules

Show full inclusion / exclusion criteria
A. Stroke, brain tumor, or traumatic brain injury patients

Inclusion Criteria:

1. At least 18 years of age.
2. Capable of providing informed consent and complying with study procedures.
3. Unilateral or bilateral focal brain damage causing loss of vision.
4. At least three months post-stroke or traumatic brain injury, or a stable brain tumor within the past year.

Exclusion Criteria:

1. Severe CNS diseases or disorders unrelated to the focal lesion, which could interfere with study results.
2. Severe mental health challenges that could interfere with study results, or current or recent (within the past 6 months) drug or alcohol abuse or addiction as defined by DSM-5.
3. Vision loss resulting from ocular disease or disorder.

B. Healthy volunteers (age-matched controls):

Inclusion Criteria:

1. At least 18 years of age.
2. Capable of providing informed consent and complying with study procedures.

Exclusion Criteria:

1. Any CNS diseases or psychiatric disorders (e.g., epilepsy, schizophrenia) that would interfere with study results.
2. Previous head injury.
3. Present or past (within past 6 months) drug or alcohol abuse or addiction based on DSM-5.

Where it's running

  • Georgetown University Medical Center
    Washington D.C., District of Columbia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Home-based vision training guided by brain imaging

    This study tests whether at‑home, image-guided visual training can improve visual field function for adults with stroke-related vision loss.

    Recruiting Georgetown University · Washington D.C., District of Columbia · NCT07635329

  • Visual retraining after stroke

    We will try an intensive home-based visual retraining program for adults with cortical vision loss after stroke to see if it improves visual perception and everyday use of vision.

    Recruiting University of Rochester · Rochester, New York · NCT06121219

  • Understanding how vision loss affects driving in virtual reality

    This study tests how vision loss from a stroke affects driving skills in a virtual reality setting to help understand the challenges faced by people with visual field defects.

    Recruiting University of Rochester · Rochester, New York · NCT06047717

  • Remote neuropsychological assessments for patients with neurological disorders

    This study is testing a new online way to check brain function in patients with neurological disorders who have trouble getting to appointments.

    Recruiting Umeå University · Umeå · NCT05819008

  • Electrical stimulation-assisted exercise for people with lower limb paralysis

    This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.

    Recruiting Louis Stokes VA Medical Center · Cleveland, Ohio · NCT07768761

  • ZEPU-2000 robotic rehab for arm and leg weakness

    This trial tests whether adding ZEPU-2000A, ZEPU-2000D, and ZEPU-2000E robotic rehabilitation to usual therapy helps adults with arm/leg movement problems from stroke, incomplete SCI, TBI, or related conditions.

    Recruiting Bangladesh Medical University · Dhaka · NCT07749612

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.